Second woman possibly cured of HIV
CRISPR gene therapy EBT-101 does not prevent HIV viral rebound
Drugs that make HIV-infected cells self-destruct induce profound viral load drops in mice after just one or two doses
Some children who start antiretrovirals very early may control HIV after stopping treatment
Varying dolutegravir distribution across the body may affect the drug’s ability to suppress the HIV reservoir
Young people want research to focus on a cure for HIV, sharing their status and U=U
How do participants feel about analytical treatment interruptions in HIV cure-directed trials?
Gene editing may not be the safest HIV cure strategy, early findings warn
Nearly 13% of participants in an African cohort maintain HIV control off treatment
